Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24354765)

1.

Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D.

Jung K, Feldman R, McBean AM.

Health Serv Res. 2014 Jun;49(3):910-28. doi: 10.1111/1475-6773.12145. Epub 2013 Dec 19.

2.

How Effective Is the Medicare Part D Drug Plan?

Grootendorst P.

Ann Intern Med. 2015 Jun 16;162(12):869-70. doi: 10.7326/M15-0953. No abstract available.

PMID:
26075759
3.

Common statin side effects explain poor compliance.

Dimmitt SB, Stampfer HG, Warren JB.

Br J Clin Pharmacol. 2015 Jul;80(1):170-1. doi: 10.1111/bcp.12594. Epub 2015 Jun 1. No abstract available.

PMID:
25612768
4.
5.

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.

Muntner P, Yun H, Sharma P, Delzell E, Kent ST, Kilgore ML, Farkouh ME, Vupputuri S, Bittner V, Rosenson RS, Levitan EB, Safford MM.

Am J Cardiol. 2014 Sep 15;114(6):826-31. doi: 10.1016/j.amjcard.2014.06.009. Epub 2014 Jul 1.

PMID:
25103917
6.

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2014 Aug;20(8):862-76.

7.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

8.

Geographic variation in medication adherence in commercial and Medicare part D populations.

Couto JE, Panchal JM, Lal LS, Bunz TJ, Maesner JE, O'Brien T, Khan T.

J Manag Care Spec Pharm. 2014 Aug;20(8):834-42.

9.

Impact of medicare part D plan features on use of generic drugs.

Tang Y, Gellad WF, Men A, Donohue JM.

Med Care. 2014 Jun;52(6):541-8. doi: 10.1097/MLR.0000000000000142.

10.

Incident user cohorts for assessing medication cost-offsets.

Stuart B, Loh FE, Roberto P, Miller L.

Health Serv Res. 2014 Aug;49(4):1364-86. doi: 10.1111/1475-6773.12170. Epub 2014 Mar 15.

PMID:
24628528
11.

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.

Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.

J Manag Care Spec Pharm. 2014 Mar;20(3):283-90.

12.

Generic initiation and antidepressant therapy adherence under Medicare Part D.

Bao Y, Ryan AM, Shao H, Pincus HA, Donohue JM.

Am J Manag Care. 2013 Dec;19(12):989-98.

13.

Should eligibility for medication therapy management be based on drug adherence?

Stuart B, Loh E, Miller L, Roberto P.

J Manag Care Pharm. 2014 Jan;20(1):66-75.

14.

Socioeconomic characteristics of enrollees appear to influence performance scores for medicare part D contractors.

Young GJ, Rickles NM, Chou CH, Raver E.

Health Aff (Millwood). 2014 Jan;33(1):140-6. doi: 10.1377/hlthaff.2013.0261.

PMID:
24395946
15.
16.

Moving branded statins to lowest copay tier improves patient adherence.

Chen SY, Shah SN, Lee YC, Boulanger L, Mardekian J, Kuznik A.

J Manag Care Pharm. 2014 Jan;20(1):34-42.

17.

Digesting the doughnut hole.

Joyce GF, Zissimopoulos J, Goldman DP.

J Health Econ. 2013 Dec;32(6):1345-55. doi: 10.1016/j.jhealeco.2013.04.007. Epub 2013 May 6.

18.

Demand for prescription drugs under non-linear pricing in Medicare Part D.

Jung K, Feldman R, McBean AM.

Int J Health Care Finance Econ. 2014 Mar;14(1):19-40. doi: 10.1007/s10754-013-9137-2. Epub 2013 Nov 9.

PMID:
24214101
19.

Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.

Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman LM, Stuart B, Beardsley R, Brown C.

Clin Ther. 2013 Oct;35(10):1513-1525.e1. doi: 10.1016/j.clinthera.2013.09.001.

PMID:
24139423
20.

Medicare Part D plan generosity and medication use among dual-eligible nursing home residents.

Huskamp HA, Stevenson DG, O'Malley AJ, Dusetzina SB, Mitchell SL, Zarowitz BJ, Chernew ME, Newhouse JP.

Med Care. 2013 Oct;51(10):894-900. doi: 10.1097/MLR.0b013e31829fafdc.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk